TherapeuticsMD, Inc.
TXMD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000025743
No open-market purchases or sales by TherapeuticsMD, Inc. insiders were filed in the last 90 days; 44 institutions reported holding it in 13F filings for Q2 2026, worth $8.10M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in TherapeuticsMD, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- +3 vs. Q3 2023
- Shares held
- 3.25M
- +264.4K (+8.9%) vs. Q3 2023
- Total value
- $7.32M
- −$1.71M (−18.9%) vs. Q3 2023
- New holders
- 6
- 4 more added
- Sold out
- 3
- 12 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TXMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 44 | $8.10M |
| Q1 2026 | 49 | $7.94M |
| Q4 2025 | 44 | $5.52M |
| Q3 2025 | 46 | $3.54M |
| Q2 2025 | 42 | $3.78M |
| Q1 2025 | 42 | $3.09M |
| Q4 2024 | 41 | $3.03M |
| Q3 2024 | 37 | $5.61M |
| Q2 2024 | 38 | $5.49M |
| Q1 2024 | 43 | $7.73M |
| Q4 2023 | 39 | $7.32M |
| Q3 2023 | 36 | $9.02M |
| Q2 2023 | 42 | $12.5M |
| Q1 2023 | 41 | $11.7M |
| Q4 2022 | 44 | $19.4M |
| Q3 2022 | 43 | $13.8M |
| Q2 2022 | 53 | $20.3M |
| Q1 2022 | 125 | $40.4M |
| Q4 2021 | 132 | $44.1M |
| Q3 2021 | 150 | $98.2M |
| Q2 2021 | 155 | $203.9M |
| Q1 2021 | 162 | $237.0M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding TherapeuticsMD, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rubric Capital Management LP | 1,192,191 | $2.68M | 0.10% | 00.0% | Unchanged |
| Clearline Capital LP | 466,211 | $1.05M | 0.12% | +10,823+2.4% | Added |
| Tejara Capital Ltd | 401,937 | $904.4K | 0.38% | +32,343+8.8% | Added |
| Vanguard Group Inc | 387,582 | $872.1K | 0.00% | +2,334+0.6% | Added |
| ADAR1 Capital Management, LLC | 272,160 | $612.4K | 0.27% | +272,160 | New |
| BlackRock Inc. | 136,263 | $306.6K | 0.00% | −242−0.2% | Reduced |
| Morgan Stanley | 131,767 | $296.5K | 0.00% | −1,377−1.0% | Reduced |
| Geode Capital Management, LLC | 84,788 | $190.8K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 42,000 | $94.5K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 30,100 | $67.7K | 0.00% | −28−0.1% | Reduced |
| Gabelli Funds LLC | 29,000 | $65.3K | 0.00% | −2,000−6.5% | Reduced |
| Ameriprise Financial Inc | 22,479 | $50.6K | 0.00% | −17−0.1% | Reduced |
| Northern Trust Corp | 16,491 | $37.1K | 0.00% | 00.0% | Unchanged |
| J. Goldman & Co LP | 13,562 | $30.5K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 10,154 | $22.8K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 8,289 | $18.6K | 0.00% | −30.0% | Reduced |
| AJOVista, LLC | 2,151 | $4.84K | 0.01% | +2,151 | New |
| UBS Group AG | 1,272 | $2.86K | 0.00% | +575+82.5% | Added |
| Banque Cantonale Vaudoise | 1,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 720 | $1.67K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 409 | $920 | 0.00% | −8,101−95.2% | Reduced |
| Wells Fargo & Company | 320 | $720 | 0.00% | −10−3.0% | Reduced |
| JPMorgan Chase & Co | 293 | $659 | 0.00% | −20−6.4% | Reduced |
| US Bancorp | 246 | $554 | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 140 | $314 | 0.00% | 00.0% | Unchanged |
| Principal Securities, Inc. | 126 | $284 | 0.00% | +126 | New |
| Huntington National Bank | 120 | $270 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 63 | $142 | 0.00% | +63 | New |
| Advisor Group Holdings, Inc. | 36 | $81 | 0.00% | −215−85.7% | Reduced |
| Provenance Wealth Advisors, LLC | 20 | $45 | 0.00% | 00.0% | Unchanged |
| Focused Wealth Management, Inc | 16 | $36 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 11 | $25 | 0.00% | −928−98.8% | Reduced |
| Birchbrook, Inc. | 10 | $23 | 0.00% | +10 | New |
| Harbour Investments, Inc. | 8 | $18 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 2 | $5 | 0.00% | 00.0% | Unchanged |
| Guardian Wealth Management, Inc. | 2 | $5 | 0.00% | 00.0% | Unchanged |
| Aspire Private Capital, LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 154 | $0 | 0.00% | −2,540−94.3% | Reduced |
| Householder Group Estate & Retirement Specialist, LLC | 30 | $0 | 0.00% | +30 | New |
| Sanders Morris Harris LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −15,619−100.0% | Sold out |
| Legacy Financial Group LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |